Burjeel Hospital Launches ‘Burjeel Center for Interventional Pain Management' in Dubai
'The launch of this center further strengthens our clinical capabilities and reaffirms our commitment to delivering advanced, patient-centered care. Our goal is to ensure that every individual suffering from chronic pain has access to timely, specialized care that empowers them to live better,' said Mr. Safeer Ahamed.
Redefining Pain Management
Led by Dr. Manish Raj, Specialist in Endoscopic Spine & Interventional Pain Medicine, the Burjeel Center for Interventional Pain Management is designed to provide expert pain management services that align with global standards. The multidisciplinary team at the center employs interventional medicine to diagnose and treat pain. These image-guided, minimally invasive procedures minimize recovery time and improve patient outcomes.
Using a patient-centered approach, the center brings together experts from Endoscopic spine surgery, minimally invasive pain interventions, interventional pain medicine, physiotherapy, and oncology to deliver integrated and personalized care. Combining world-class clinical expertise with advanced technology, it plays a crucial role in diagnosing and treating chronic spine and joint pain, cancer-related pain, as well as nerve and musculoskeletal disorders. It offers innovative procedures such as endoscopic spine surgery, SI joint fusion, indirect fusion, endoscopic-assisted fusion, spinal cord stimulator, intrathecal pump and many more advanced day care pain interventions.
'At the center, we aim to provide transformative care that goes beyond temporary relief. Our multidisciplinary approach harnesses cutting-edge diagnostics and evidence-based therapies to empower patients to reclaim their lives, free from the limitations of chronic pain,' said Dr. Manish Raj.
Targeted Treatments, Personalized Care
Conditions treated at the center include chronic back and neck pain, sciatica, spinal stenosis, herniated discs, degenerative disc disease, osteoarthritis, failed back surgery syndrome, and vertebral fractures. Patients also receive care for diabetic or post-injury neuropathy, shingles (PHN), trigeminal neuralgia, Complex Regional Pain Syndrome (CRPS), migraines, and myofascial pain. Cancer and visceral pain, including tumor-related discomfort and chronic abdominal or pelvic pain, are managed through tailored treatment strategies.
The center offers advanced pain interventions, including spinal cord and DRG stimulation for CRPS and post-surgical pain, intrathecal pump implants for targeted medication delivery in cancer and chronic cases, and regenerative therapies like PRP and prolotherapy for sports injuries or osteoarthritis. It also provides specialized nerve blocks and image-guided injections for joint, migraine, pelvic, and complex pain management.
By focusing on early intervention, integrated therapies, and increasing access to specialized care, the center is poised to improve quality of life for patients across the region.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Bawaba
2 days ago
- Al Bawaba
Al Jalila Foundation Supports 60 Organ Transplant Patients through 'Your Donation Saves Lives' Campaign
Al Jalila Foundation, the philanthropic arm of Dubai Health, announced that it has contributed to saving the lives of 60 patients by supporting organ transplant surgeries as part of the first and second editions of the Your Donation Saves Lives announcement coincides with World Organ Donation Day, observed annually on 13 August, and reflects the Foundation's long-term commitment to supporting patients with organ failure and fostering a culture of organ donation as a humanitarian its launch in April 2021, the campaign has supported 60 transplant procedures, including 53 kidney transplants and 7 liver transplants. Among these are 24 children with kidney failure and 5 children with liver failure. As part of this program, the Foundation continues to support more than 65 patients with life-saving transplants, who are unable to access or afford specialized efforts are aligned with the goals of HAYAT, the National Program for Organ and Tissue Donation and Transplantation and are carried out in partnership with Dubai Health's integrated academic health system. From Campaign to Permanent ProgramDr. Amer Al Zarooni, CEO of Al Jalila Foundation, announced that the Your Donation Saves Lives campaign has now evolved into a permanent initiative under the Foundation's A'awen program, which provides financial assistance to patients in need of critical medical treatment across the UAE, a step that aligns with Dubai Health's commitment, 'Patient First'.'On World Organ Donation Day, we reaffirm our commitment to supporting patients with organ failure and extend our heartfelt thanks to the generous donors, individuals and institutions alike, who contributed to both the first and second editions of the Your Donation Saves Lives campaign. Their support represents a powerful model of human solidarity, with the first edition alone helping to fund nearly 30% of all organ transplants performed in Dubai,' said Dr. Al also extended his appreciation to living organ donors and to the families of deceased donors, saying: 'Your compassion has given others a second chance at life. We thank you for your extraordinary generosity.'Ensuring Safe, Successful TransplantsDr. Ashraf Al Hinnawi, Consultant Transplant Surgeon at Dubai Health, explained that the medical team works collaboratively to thoroughly evaluate both the donor and the recipient before transplantation, ensuring the highest possible long-term success rates.'We conduct comprehensive assessments of kidney function and immune compatibility between the donor and recipient, along with detailed medical and surgical evaluations that include lab tests and imaging studies to ensure the success of the transplant. We also follow up with patients regularly after the procedure to ensure adherence to the treatment plan and to closely monitor kidney function.'Regarding living donors, Dr. Al Hinnawi noted that they undergo meticulous evaluations, including assessment of the kidneys, functional testing, and screening for any infectious or cancerous conditions, in addition to psychological and social assessments. He added that all cases are reviewed by a multidisciplinary medical committee to determine donor eligibility, ensuring the highest levels of safety for both donor and recipient.A Lifeline for Patients in NeedAl Jalila Foundation continues to welcome donations through A'awen, offering individuals and organizations the opportunity to fund life-changing programs that enhance well-being and provide essential medical first edition of the campaign was launched in April 2021 in collaboration with Mohammed Bin Rashid University of Medicine and Health Sciences, the Islamic Affairs and Charitable Activities Department, and Emarat Al Youm newspaper. The second edition took place in September 2024 and concluded in December of the same year, as part of a collaboration between the Islamic Affairs and Charitable Activities Department, Al Jalila Foundation, and Emarat Al Youm surgeries were conducted in partnership with Dubai Health's Dubai Hospital and Al Jalila Children's Hospital, alongside Mediclinic City Hospital and King's College Hospital London in of HopeYousef's New BeginningAmong the beneficiaries of the campaign, is the child Yousef Jashim, who underwent a kidney transplant with the support of Al Jalila Foundation. Yousef suffered from constant fatigue and recurring pain and was undergoing regular dialysis sessions that significantly affected his daily life and imposed strict dietary restrictions. When he turned fourteen, the doctors informed his family of the necessity of a kidney transplant as an essential step in his treatment Jalila Foundation's support was instrumental, helping the family cover the cost of the the transplant, Yousef's life transformed. He regained his energy and no longer required mother expressed deep gratitude to Al Jalila Foundation, the medical teams involved in his care, and the wider community whose support helped save her son's Healing JourneyRoula Tabba'a is also among the beneficiaries of the campaign, following a long journey with kidney failure. She underwent dialysis three times a week, which caused severe physical and emotional exhaustion. Her condition was first diagnosed in 2016, and she underwent several Jalila Foundation covered the cost of her dialysis sessions and medical tests, eventually supporting her inclusion in the kidney transplant years of waiting, Roula received a life-changing call from the medical team confirming that she had been approved for the procedure. Thanks to the dedication of the medical staff, the transplant was life was completely transformed following the surgery, she no longer needed dialysis and regained her ability to move freely, travel, and live independently. Roula expressed her deep gratitude to Al Jalila Foundation, saying its support not only saved her life, but also restored hope and stability for her entire family.
Al Bawaba
31-07-2025
- Al Bawaba
Al Jalila Foundation and Dubai International Arbitration Centre join forces to support transformative healthcare
Al Jalila Foundation, the philanthropic arm of Dubai Health, has announced a strategic partnership with the Dubai International Arbitration Centre (DIAC), the largest arbitral institution in the Middle East, Africa and South Asia region, to strengthen community outreach and advance health initiatives through joint charitable collaboration will bring together the healthcare and legal sectors in support of Al Jalila Foundation's mission, through community engagement, donor outreach, and awareness part of the agreement, DIAC's name will be added to Al Jalila Foundation's donor recognition wall, commemorating their generous contribution, and the Foundation will be recognized as a charitable partner across DIAC's communication agreement reflects the goals of the UAE Year of Community and highlights both organizations' commitment to creating sustainable impact. By strengthening cross-sector collaboration, the initiative supports national efforts to promote a collective sense of social Amer Al Zarooni, CEO of Al Jalila Foundation, said: 'We are proud to partner with DIAC in a collaboration that reflects our shared vision of building a healthier and more compassionate society. Their support enables us to expand our reach and deepen our impact within the community.'He added: 'Strategic alliances like this are key to our mission. They allow us to work across sectors, leverage expertise and create sustainable, lasting change in people's lives.'Jehad Kazim, Executive Director of Dubai International Arbitration Centre said: Our partnership with Al Jalila Foundation reflects DIAC's commitment to supporting initiatives that strengthen our communities. Together, we're bringing the legal and healthcare sectors closer to address shared challenges and deliver meaningful benefits. This collaboration marks an important step in our efforts to contribute to a healthier, more connected society.' Earlier this year, DIAC hosted a Ramadan Charity Suhoor that raised over AED 100,000 to support The Child Fund by Al Jalila Foundation, highlighting the organization's dedication to social impact.
Al Bawaba
30-07-2025
- Al Bawaba
Gulf Capital Successfully Exits ART Fertility Clinics' Middle East Operations Selling Its Stake to IVI-RMA Global, World Leader in Fertility and Assisted Reproduction
Gulf Capital, one of the largest private equity firms investing from the GCC to the rest of Asia, announced today that it has sold its majority stake in ART Fertility Clinics' Middle East operations to IVI-RMA Global, the world's largest assisted reproduction group. The transaction is expected to generate a significant return on invested capital, making it one of Gulf Capital's most successful exits to its acquisition in 2020, ART Fertility Clinics has undergone a period of significant growth and transformation. Under Gulf Capital's ownership, ART expanded from a UAE-focused business into a regional fertility platform with 15 clinics, including 3 in the UAE, 1 in Saudi, and 11 in India. The scope of the transaction includes the clinics located in UAE and Saudi Arabia, while the India operation will remain under the ownership of Gulf Capital. In the Middle East alone, ART Fertility Clinics has delivered substantial revenue and EBITDA growth since 2020, with profitability quadrupling over the last five years. This strong financial performance has been underpinned by ART's reputation for clinical excellence, rapid regional expansion and some of the highest success rates in IVF treatments across the Karim El Solh, Co-Founder and CEO of Gulf Capital, commented: 'We are proud of the transformation we achieved at ART Fertility, scaling the platform from a single-country operator to the regional leader in reproductive medicine. Under Gulf Capital's ownership, ART Fertility invested heavily in science and research with 220 medical publications to date and launched a pioneering genetic testing lab in Abu Dhabi, leading to some of the highest IVF fertility success rates globally. ART Fertility's expansion and financial performance underline Gulf Capital's deep focus on operational improvements and growth. Following a competitive auction, the successful sale of the company to a global strategic buyer highlights Gulf Capital's ability to source, grow and exit healthcare platforms at very attractive multiples.'Suresh Soni, CEO of ART Fertility Clinics, said: 'ART Fertility has built a strong reputation for clinical excellence and world-class patient outcomes. Our success has been driven by our scientific rigor, a world-renowned medical team led by Prof. Dr Human Fatemi, and a deep commitment to providing the best-in-class care. With the support of Gulf Capital, we were able to expand successfully across the region and enhance our service offerings including adding in house genetic capabilities. We are excited to join IVI-RMA's global platform and to continue delivering on our mission and commitment towards the GCC community.'Hazem Abu Khalaf, Managing Director and Head of Healthcare investments at Gulf Capital, added: 'Our investment in ART Fertility is a clear example of Gulf Capital's ability to drive operational improvement and strategic growth in high-impact sectors. As one of the most vital and fast-evolving industries in the GCC, healthcare continues to offer both meaningful impact and long-term growth opportunities. ART Fertility stands as a testament to that potential. Over the past few years, we have helped build a business that combines scale, profitability, and clinical leadership – three elements that are often difficult to align. We are confident that ART Fertility is well-positioned for continued success in its next phase of growth under IVI-RMA's ownership and proud to have laid the foundation for its continued success in advancing specialized healthcare in the region'. Gulf Capital and ART Fertility Clinics were advised by Moelis & Company as M&A advisor, and A&O Shearman as legal advisor on the transaction.
